Loading provider…
Loading provider…
Pediatrics Physician in Allentown, PA
NPI: 1275714024Primary Practice Location
Children Healthcare
1517 Pond Rd, Allentown, PA
HQ Phone
Get MD Lydia's Phone Numberphone_androidMobile
Get MD Lydia's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
PA State Medical License
NC State Medical License
2009 - 2013

null, PA
2012 - 2026

American Board of Pediatrics
Pediatrics

American Board of Pediatrics
Pediatric Hematology-Oncology
Duke University Hospital
Fellowship • Pediatric Hematology/Oncology
2009 - 2012
East Tennessee State University/Quillen College of Medicine
Residency • Pediatrics
2006 - 2009
University of Science and Technology SOM
Medical School
Until 2002
Sickle red blood cells directly activate neutrophils.
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, RADIATION: External Beam Radiation Therapy, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, PROCEDURE: Therapeutic Conventional Surgery, DRUG: Busulfan, DRUG: Topotecan Hydrochloride, DRUG: Cyclophosphamide, DRUG: Isotretinoin, DRUG: Vincristine Sulfate, PROCEDURE: Computed Tomography, PROCEDURE: Multigated Acquisition Scan, BIOLOGICAL: Dinutuximab, PROCEDURE: Echocardiography, BIOLOGICAL: Sargramostim, PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation, DRUG: Thiotepa, RADIATION: Iobenguane I-131, DRUG: Doxorubicin Hydrochloride, DRUG: Melphalan Hydrochloride, PROCEDURE: Bone Marrow Aspiration and Biopsy, RADIATION: Iobenguane I-123, DRUG: Etoposide Phosphate, DRUG: Lorlatinib, DRUG: Dexrazoxane Hydrochloride
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, RADIATION: Radiation Therapy, DRUG: Cyclophosphamide, DRUG: Vincristine Sulfate, DRUG: Lomustine, DRUG: Vincristine
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI), EsPhALL
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, DRUG: Doxorubicin, DRUG: Dexamethasone, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Ifosfamide, DRUG: Etoposide, DRUG: Vincristine Sulfate, DRUG: Methotrexate, DRUG: Methylprednisolone, BIOLOGICAL: Filgrastim, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, DRUG: Mercaptopurine, DRUG: Calaspargase Pegol, DRUG: Prednisolone, DRUG: Imatinib Mesylate, DRUG: Therapeutic Hydrocortisone, DRUG: Thioguanine, DRUG: Pegaspargase, DRUG: Leucovorin Calcium, DRUG: Daunorubicin Hydrochloride, DRUG: Levoleucovorin, DRUG: Dexrazoxane Hydrochloride